Healthcare 2008

• Programme
• Venue
• Participating Companies
• Sponsorship
• Marketing material

Buy conference papers

Sponsor

Official Knowledge Partner

Determining the market for a new vaccine

Abstract

• Last Patient Analysis (LPA) is a patient diary review technique that provides a picture of actual patient profiles and referral (a patient path), the underlying reasons and attitudes for disease treatment and prescription usage, and the intent to prescribe a new treatment to each patient.
• LPA is a statistically robust research product as typically each physician is easily able to describe up to 6 patient cases, which means that 100 interviews generate 600 cases. Medimix International and Sanofi-Pasteur are detailing 1,740 quantitative interviews from the US, France, Germany and Italy with oncologists and dermatologists on the subject of a new Melanoma vaccine.
• There is a continuous evolution of immune cancer response understanding as newer antigen targets are being studied which may improve the effectiveness of anti-tumor vaccines. The development and effective marketing of a melanoma vaccine would be a revolution in the efficient treatment of melanoma.
• Medimix will present the diary review technique explaining how one can analyze in-depth patient path, treatment algorithm and patient needs.

Henry Gazay

Henry Gazay founded Medimix International in 1989, in Paris. Headquarters were moved to Miami FL USA in 1999, with additional offices in London, Sao Paulo and Florham Park, NJ.

Henry has always worked exclusively in healthcare marketing research, and has managed more than 300 surveys & missions in more than 50 countries around the world. In 1999, he was appointed EEC expert to assess European community investment programs by conducting international marketing research throughout Europe and Latin America. Henry is member of PBIRG, EphMRA, Esomar, AMA and Conseiller du Commerce Extérieur pour la France, by appointment of the French Minister of foreign affairs. He graduated from Ecole Centrale in Lyon, with a specialization in data processing and statistics.

< BACK

Corinne Hardy

Corinne is Director, Market & Business Research at sanofi pasteur, the vaccine division of sanofi aventis.
She holds degrees in biochemistry and biology from the University of Lyon and a marketing MBA from the Lyon Business School.

Her special research interests are evaluation of R&D or licensing in projects and development of strategic plans.


< BACK